Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty global pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the...
Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center of Dallas, TX are proud to announce the establishment of the SRT University™ Comprehensive Education Series for practitioners, healthcare...
MISSISSAUGA, ON, May 18, 2012 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced it will be showcasing its advanced medical coating...
Surgeons using endoscopy to stalk pathology know that sharper views enhance treatments and improve patients' outcomes. But until now, high-definition endocams have been too expensive for many physicians in private...
Intellect Neurosciences, Inc. (OTCPK: ILNS) announces that Dr. Daniel G. Chain, the company's chairman and CEO, will be presenting at the Seventh Annual Neurotech Investing and Partnering Conference.
Generex Biotechnology Corporation (OTCBB: GNBT) announced today that additional members have joined the Scientific Advisory Board (SAB) of its wholly-owned subsidiary, Antigen Express, Inc., for the company's AE37 breast...
Champions Oncology Inc. (OTC: CSBR) announced today that it has received U.S. Clinical Laboratory Improvement Amendment (CLIA) certification from the Maryland Department of Health and Mental Hygiene Office of Health Care...
Boston Scientific Corporation (NYSE: BSX) announces that seven abstracts and additional clinical data analyses will be presented at Digestive Disease Week® (DDW), May 19 – 22 in San Diego. The analyses involve the SpyGlass®...
Receptos Inc. today announced that company personnel will deliver a scientific podium presentation about RPC1063 at the Digestive Disease Week (DDW) annual meeting at 9 a.m. PDT on Sunday, May 20, 2012 at the San Diego...
Ocera Therapeutics Inc., a privately-held biopharmaceutical company focused on the development and commercialization of proprietary agents to treat gastrointestinal and liver diseases, announced today that it has received a...
The new arthroscopy simulator ArthroS trains orthopedic surgeons for real patients - with a unique setup The Swiss company VirtaMed AG is launching ArthroS™, a new virtual reality training simulator for knee arthroscopy....
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that a new publication from the large Women & Infants multi-center clinical study on the Sequenom...
Boston Scientific Corporation (NYSE: BSX) announces two-year results from the PLATINUM Small Vessel study, demonstrating excellent safety and effectiveness outcomes for the 2.25 mm PROMUS Element™ Everolimus-Eluting Platinum...
The Belgian biotechnology company, Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces that the final...
ReportsnReports.com adds new market research reports on "Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018" for multiple countries. These reports provide value (USD million), volume (units) and...
Sequenom Inc., (NASDAQ: SQNM) through its wholly owned subsidiary Sequenom Center for Molecular Medicine, LLC, (Sequenom CMM) entered into the recently announced provider network participation agreement with Coventry Health...
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced efficacy and safety results from a Phase II trial of urocortin 2 in 53 patients with acute decompensated heart failure. The UNICORN study was conducted over...
Ventac Partners and the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences (GIBH) today announced the creation of CASiGEN Pharma Ltd. (CASiGEN) to bring new treatments for diabetes and other metabolic...
Esperance Pharmaceuticals today announced that it has begun enrollment of a Phase 2, randomized, multi-center trial of EP-100 in combination with paclitaxel for the potential treatment of advanced ovarian cancer. EP-100 is a...
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for...
Sigma-Aldrich Corporation (NASDAQ: SIAL) will be presenting at the following investor conferences in June:
Amy Langan, Vice President of Marketing and Business Development, announced that PharMEDium will highlight its enhanced labeling for sterile intravenous compounded ICU Services at the National Teaching Institute (NTI) and...
Simbionix USA Corporation, the world's leading provider of medical simulation, training and education products, is proud to announce the release two new platform designs this week: the new GI Mentor™ Express simulator...
Ruga Corporation, a privately held oncology company focused on the discovery and development of personalized therapeutics targeting tumor-selective adaptive responses, announced today that as part of its drug adaptation...
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, will host an investor call to update...
The "Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study" analyzes and studies the U.S. market for intravenous anesthesia drugs with special focus on ketamine, distribution structure of anesthesia drugs in U.S.,...
Egalet Ltd., a privately held specialty pharmaceutical company focused on developing safe, effective and abuse-deterrent medications, announced today Bob Radie, president and chief executive officer (CEO), will present at...
Ambit Biosciences and Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) ("Teva") today announced the clearance of an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) for...
China Botanic Pharmaceutical Inc. (NYSE AMEX: CBP) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines ("TCM") in China,...
InspireMD, Inc. (OTC BB: NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial...
Ceregene Inc., a biotechnology company developing treatments for neurodegenerative diseases such as Parkinson's disease, will present new data demonstrating long-term, biologically-active expression of neurturin, a...
Pharmaceutical companies that are first to meet healthcare's new expectations of value could have an advantage in the competition for market share and brand differentiation, according to a report published today by the...
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and FCB I LLC ("FCB") today announced that the United States Patent and Trademark Office ("USPTO") has issued U.S. Patent No. 8,178,518 covering, among other things,...
ChromaDex® Corporation (OTCBB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day on Thursday, May 31, 2012, from 8:30 a.m. to...
Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that clinical abstracts on Bruton's Tyrosine Kinase inhibitor, ibrutinib (formerly, PCI-32765) have been selected for oral presentations at the 48th Annual Meeting of...
SHANGHAI, May 17, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today...
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced the results of a retrospective subpopulation analysis of 183 patients with cancer from the company's two large Phase 3 trials, which showed the cancer patients...
Van Andel Research Institute (VARI) and Dako, the Danish-based, worldwide supplier of cancer diagnostic tools today announce an agreement to license, manufacture and distribute cancer diagnostics utilizing the MET4 Antibody.
Sigma-Aldrich announced today that it has established a new $600 million revolving credit facility that will mature on May 10, 2017. The new facility replaces a $450 million revolving credit facility that was scheduled to...
Zyga Technology announced today that it had raised $25 million in a Series C financing led by new investor Versant Ventures of Menlo Park, California. Joining Versant in this round are existing investors Split Rock...
QUEBEC CITY, May 16, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced today that it has received a notice from The NASDAQ Stock Market indicating that the Company's minimum...
Scientific Certification Systems (SCS) is the first certification body in the United States to be accredited by the International Sustainability & Carbon Certification (ISCC) biofuel certification system. SCS has been...
Adaptive Biotechnologies Corporation, a leading provider of next-generation sequencing assays for the adaptive immune system, announced today results from the first head-to-head comparison of high throughput sequencing (HTS)...
Reportlinker.com announces that a new market research report is available in its catalogue:
Avalanche Biotechnologies, Inc., a leader in the area of long-term protein delivery for ocular diseases, and Lonza, a global leader in the field of biologics manufacturing, today announced a manufacturing collaboration...
PROLOR Biotech, Inc. (NYSE MKT: PBTH; TASE: PBTH), today announced the closing of its previously announced underwritten public offering. At the closing, PROLOR issued 7,475,000 shares of its common stock at a price to the...
Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases,...
Star Scientific, Inc. (NASDAQ: CIGX) announced that the U.S. Patent and Trademark Office ("PTO") issued a Notice of Allowance on May 11, 2012 to Rock Creek Pharmaceuticals, Inc., its wholly owned subsidiary, in Application...
GeneThera, Inc. (OTCQB: GTHR) announced today that Applied Genetics, GeneThera's majority owned subsidiary, signed a research and test validation agreement with Universidad National Autonoma de Mexico (UNAM). Scope of...
UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that it has signed a television joint venture agreement with Stardust International TV, of San Bernardino Ca., for the filming of a 60 second...
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced the pricing of an underwritten public offering of 11,000,000 shares of its common stock, offered at a price to the public of $5.50 per share. The gross proceeds to...
NeuroPerspective, the independent, monthly review of the neurotherapeutics area, has released its May issue, which assesses the field of therapeutics for stroke.
Syndax Pharmaceuticals, Inc., an oncology company moving into phase 3 having completed randomized, placebo controlled phase 2 studies, announced Luke Evnin, Ph.D. will join the board of directors replacing Steven St. Peter,...
Although there are approximately 27 drugs on the market indicated for the treatment of breast cancer, there is currently an unmet need to treat patients. Consequently, there are abounding opportunities for pharmaceutical...
Reportlinker.com announces that a new market research report is available in its catalogue:
Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced the appointments of Donald J. Hayden, Jr. as Executive Chairman of the Company's Board of Directors, and Randall Whitcomb, M.D. as the...
Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that HealthTrust Purchasing Group, L.P., (HealthTrust) is renewing its agreement...
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce representatives from the Company will present preclinical research findings for MCT-465 and MCT-485 at CIMT 2012 (http://meeting.cimt.eu),...
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that its Board of Directors has increased the Company's common share repurchase program authorization by an additional 5 million shares.
Reportlinker.com announces that a new market research report is available in its catalogue:
Rigel Pharmaceuticals, Inc., (Nasdaq: RIGL) is expanding its respiratory franchise by focusing on two innovative, comprehensive treatment alternatives for patients with asthma. One of these agents, R343, an inhaled SYK...
NuMe Health LLC, a biotechnology company developing evidence-based cobiotic™ products that modify the bacteria that live in the gastrointestinal (GI) tract to support health and well-being, today announced that it has closed...
Rubicon Genomics, Inc., a leader in the development and commercialization of sample-specific pre-analytical processes to improve the performance and capabilities of DNA and RNA analytical platforms for research and clinical...
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced that its majority-owned subsidiary, NSVascular, Inc. (NSV), acquired a portfolio of patents and related trade secrets covering the fabrication of...
Decision Resources Group (DRG) acquisition at approximately Rs. 3,400 CrDRG a fast growing healthcare information business - CAGR 20% from 2006 to 2011DRG's client base includes 48 out of top 50 global pharma companies...
Nile Therapeutics, Inc. (OTCQB: NLTX), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced its first quarter financial results for 2012.
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. There can be no assurance...
The board of directors of Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, has begun the process of identifying a successor to Gail S. Page, president and CEO. The board has formed a search...
Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2012 financial results and to provide a business update. Anyone...
OrbusNeich today announced that 12-month follow-up data from the REMEDEE study showed favorable clinical and safety outcomes involving the use of the company's Combo Dual Therapy Stent when compared to the TAXUS®...
GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced its financial results for the three months ended March 31, 2012 and provided a business...
VANCOUVER, May 15, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that it released its financial results for the first quarter ended March 31, 2012.
IntelligentMDx (IMDx) announced today that it has obtained CE-marking for a new automated, high-throughput, qualitative in vitro diagnostic test designed for the rapid detection of Group B Streptococcus (GBS) for use in...
Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President and Chief Financial Officer, Judy L. Brown, will present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May...
Connecting healthcare points of entry across the spanning areas of patient care is a progressing focus in the healthcare industry. Rapid transitions are expected, and already seen with the uptake of electronic health...
Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases,...
Generex Biotechnology Corporation (OTCBB: GNBT), in anticipation of the transition into pivotal Phase III trials, is pleased to announce today that the expertise of the Scientific Advisory Board (SAB) of its wholly-owned...
Cardium Therapeutics (NYSE Amex: CXM) today presented its financial results for the first quarter ended March 31, 2012, and other recent developments.
Reportlinker.com announces that a new market research report is available in its catalogue:
Reportlinker.com announces that a new market research report is available in its catalogue:
Reportlinker.com announces that a new market research report is available in its catalogue:
CoreLab Partners, Inc., a leading independent core lab providing centralized cardiac safety services and medical imaging assessment, is set to attend and actively participate in several upcoming industry events around the...
BGI, one of the world's largest genomics organizations, announced today that a new Roche GS FLX+ System has been successfully installed at its facility in Shenzhen, China. The goal is to complement the existing array of...
MISSISSAUGA, ON, May 15, 2012 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced United States Food and Drug Administration ("FDA")...
UV Flu Technologies, Inc. (OTCBB: UVFT)(the "Company") is pleased to announce that Cardis Furniture (www.cardis.com) has chosen the Company's Viratech UV-400 as the air purifier to be combined with a premium Serta...
Today, leading events organizer UBM Live announced strong booking levels for Informex 20I3, North America's leading networking event for buyers and sellers of high value chemistry. 248 exhibitors have already confirmed...
Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Steve Klosk, President and Chief Executive Officer, will make a presentation on the Company at the Jefferies 2012 Global Healthcare Conference on June 4,...
Butamax™ Advanced Biofuels, LLC announced today that the United States Patent and Trademark Office (USPTO) has granted Butamax Patent Number 8,178,328. The '328 patent covers a highly efficient engineered pathway for...
CALGARY, May 15, 2012 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the Bank of America Merrill Lynch 2012 Health...
Stimatix GI Ltd., a leading developer of low-profile innovative solutions for colostomy management, announced today that it has completed its FDA registration and device listing for its AOS-C2000™ as part of its commercial...
ReportsnReports.com announces a Flat 10% Discount on ALL market research reports by BioInformant WorldWide, LLC through June 20, 2012. Whether stem cells are to be studied functionally or based on source tissues, our...
More than one billion people worldwide have a vision condition called presbyopia(1), which is a natural decrease in the ability of the lens in the eye to change its shape to focus on close objects. We've all seen others...
PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the first quarter ended March 31, 2012. Summary financial and operating highlights include:
Solid Performance of Health Food Stores and Healthcare Practitioners, and Restructuring Being Undertaken to Enhance Profitability in Europe
Fenwick & West, a leading technology and life sciences law firm, is pleased to announce that Effie Toshav has joined the firm as a partner in its Life Sciences Group. Ms. Toshav's national practice focuses on...
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced its support of the first global hereditary angioedema (HAE) awareness day, being held on May 16th, with a new Facebook page...
